Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00001561
What this trial is testing

Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

Who this might be right for
Graft vs Host DiseaseMultiple Myeloma
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT02955550
What this trial is testing

A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Celularity Incorporated 15
Not applicableUnknownNCT01572688
What this trial is testing

Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shandong Lanjin Pharmaceuticals Co.,Ltd 60
Early research (Phase 1)Study completedNCT00091624
What this trial is testing

Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Celgene Corporation 77
Not applicableUnknownNCT04008888
What this trial is testing

A Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaPlasma Cell LeukemiaExtramedullary Plasmacytoma+6 more
Institute of Hematology & Blood Diseases Hospital, China 50
Early research (Phase 1)Ended earlyNCT00369291
What this trial is testing

CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant

Who this might be right for
Germ Cell TumorLeukemiaLymphoma+1 more
Masonic Cancer Center, University of Minnesota 19
Testing effectiveness (Phase 2)Study completedNCT01384513
What this trial is testing

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+44 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 40
Not applicableLooking for participantsNCT06365060
What this trial is testing

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Tufts Medical Center 400
Testing effectiveness (Phase 2)Study completedNCT00256880
What this trial is testing

Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05060627
What this trial is testing

Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide

Who this might be right for
Relapsed Multiple Myeloma
PETHEMA Foundation 60
Early research (Phase 1)Ended earlyNCT00800150
What this trial is testing

Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
City of Hope Medical Center 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07764861
What this trial is testing

Phase in Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Innovent Biologics (Suzhou) Co. Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT06158269
What this trial is testing

DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 40
Testing effectiveness (Phase 2)Ended earlyNCT00017069
What this trial is testing

Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
CTI BioPharma
Early research (Phase 1)Study completedNCT02513186
What this trial is testing

Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation

Who this might be right for
Plasma Cell Myeloma
Sanofi 90
Not applicableUnknownNCT05001386
What this trial is testing

In Vitro Drug Sensitivity Testing of Fresh Human Samples

Who this might be right for
Myeloproliferative DisordersLymphoproliferative Disorders
Hospices Civils de Lyon 800
Large-scale testing (Phase 3)Study completedNCT00003805
What this trial is testing

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

Who this might be right for
Bone Marrow SuppressionFever, Sweats, and Hot FlashesInfection+6 more
European Organisation for Research and Treatment of Cancer - EORTC 859
Testing effectiveness (Phase 2)Study completedNCT00131261
What this trial is testing

Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma

Who this might be right for
Multiple Myeloma
Valerio Therapeutics 25
Large-scale testing (Phase 3)Looking for participantsNCT03562169
What this trial is testing

The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

Who this might be right for
Multiple Myeloma
University of Leeds 406
Not applicableApproved For MarketingNCT05757973
What this trial is testing

Pre-Approval Access Program for Talquetamab in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
Next Page